Transient expression and characterization of the antimicrobial peptide protegrin-1 in Nicotiana tabacum for control of bacterial and fungal mammalian pathogens

Plant Cell, Tissue and Organ Culture

Volumn 115, Issue 1, 2013, Pages 99-106

  Patiño Rodríguez, Omar ^a   Ortega Berlanga, Benita ^a   Llamas González, Yessica Y ^b   Flores Valdez, Mario A ^b   Herrera Díaz, Areli ^a,c   Montes de Oca Luna, Roberto ^d   Korban, Schuyler S ^e   Alpuche Solís, Ángel G ^a  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^b CENTRO DE INVESTIGACIÓN Y ASISTENCIA EN TECNOLOGÍA Y DISEÑO DEL ESTADO DE JALISCO   (Mexico)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Alternative antibiotics; magnICON; Protegrin 1; TMV; Tobacco

Indexed keywords

AGROBACTERIUM TUMEFACIENS; ANTIMICROBIAL PEPTIDE; KLEBSIELLA PNEUMONIAE; MAGNICON; NORTHERN BLOT ANALYSIS; PROTEGRIN-1; REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTIONS; TMV;

ANTIBIOTICS; BACTERIA; ESCHERICHIA COLI; FUNGI; MAMMALS; PEPTIDES; POLYMERASE CHAIN REACTION; TOBACCO;

POLYPEPTIDES;

EID: 84882793339     PISSN: 01676857     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11240-013-0344-9     Document Type: Article

References (39)

1. Alvarez ML, Cardineau GA (2010) Prevention of bubonic and pneumonic plague using plant-derived vaccines. Biotechnol Adv 28: 184-196.
2. Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E (2008) Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 46: 567-570.
3. Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO (2011) Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS ONE 6: e25333.
4. Bradford MM (1968) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Chang C, Gu L, Fiddes JC (2000) Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55(1): 88-98.
6. Cho Y, Turner JS, Dinh N, Lehrer R (1998) Activity of protegrins against yeast-phase Candida albicans. Infect Immun 66: 2486-2493.
7. Cole A (2005) Antimicrobial peptide microbicides targeting HIV. Protein Pept Lett 12: 41-47.
8. Colgrave ML, Kotze AC, Huang YH, O'Grady J, Simonsen SM, Craik DJ (2008) Cyclotides: natural, circular plant peptides that possess significant activity against gastro-intestinal nematode parasites of sheep. Biochemistry 47: 5581-5589.
9. DeLucca AJ, Bland JM, Jacks TJ, Grimm C, Cleveland TJ (1997) Walsh, fungicidal activity of cecropin A. Antimicrob Agents Chemother 41: 481-483.
10. Field D, Connor PM, Cotter PD, Hill C, Ross RP (2008) The generation of nisin variants with enhanced activity against specific gram positive pathogens. Mol Microbiol 69: 218-230.
11. Findlay B, Zhanel GG, Schweizer F (2010) Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob Agents Chemother 54: 4049-4058.
12. Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine 23: 2042-2048.
13. Gleba Y, Klimyuk V, Marillonnet S (2007) Viral vectors for the expression of proteins in plants. Curr Opin Biotechnol 18: 134-141.
14. Hulscher ME, Grol RP, van der Meer JW (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10: 167-175.
15. Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ (2008) Cyclotides as natural anti-HIV agents. Biopolymers 90: 51-60.
16. Jenssen H, Hamill P, Hancock R (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19(3): 491-511.
17. Langham AA, Ahmad AS, Kaznessis YN (2008) On the nature of antimicrobial activity: a model for protegrin-1 pores. J Am Chem Soc 130: 4338-4346.
18. Lee SB, Li B, Jin S, Daniell H (2011) Expression and characterization of antimicrobial peptides retrocyclin-101 and protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol J 9(1): 100-115.
19. Li Y, Geng Y, Song H, Zheng G, Huan L, Qiu B (2004) Expression of human lactoferrin N-lobe in Nicotiana benthamiana with potato virus X-based agroinfiltration. Biotechnol Lett 26: 953-957.
20. Marcos JF, Munñoz A, Pérez-Payá E, Misra S, López-García B (2008) Identification and rational design of novel anti- microbial peptides for plant protection. Annu Rev of Phytopathol 46: 273-301.
21. Marillonnet S, Giritch A, Gils M, Kandzia R, Klimyuk V, Gleba Y (2003) In planta engineering of viral RNA replicons. Efficient assembly by recombination of DNA modules delivered by Agrobacterium. PNAS 101: 6852-6857.
22. Matejuk A, Leng Q, Begum MD, Woodle MC, Scaria P, Chou ST, Mixson AJ (2010) Peptide-based antifungal therapies against emerging infections. Drugs Future 35(3): 197.
23. Menassa R, Du C, Yin ZQ, Ma S, Poussier P, Brandle J, Jevnikar AM (2007) Therapeutic effectiveness of orally administered transgenic low-alkaloid tobacco expressing human interleukin-10 in a mouse model of colitis. Plant Biotechnol J 5(1): 50-59.
24. Qu X, Harwig SL, Shafer W, Lehrer R (1997) Protegrin structure and activity against Neisseria gonorrhoeae. Infect Immun 65: 636-639.
25. Rosales-Mendoza S, Paz-Maldonado LMT, Govea-Alonso DO, Korban SS (2012) Engineering production of antihypertensive peptides in plants. Plant Cell Tiss Org Cult. doi: 10. 1007/s11240-012-0231-9.
26. Rymerson RT, Babiuk LA, Menassa R, Vanderbeld B, Brandle JE (2003) Immunogenicity of the capsid protein VP2 from porcine parvovirus expressed in low alkaloid transgenic tobacco. Mol Breed 11: 267-276.
27. Saioth H, Kiba A, Nishihara M, Yamamura S, Suzuki K, Terauchi R (2000) Production of antimicrobial defensin in Nicotiana benthamiana with a potato virus X vector. MPMI 14: 111-115.
28. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 78.
29. Staub JM, Garcia B, Graves J, Hajdukiewicz P, Hunter P, Nehra N, Paradkar V, Schlittler M, Carroll J, Spatola L, Ward D, Ye G, Russell D (2000) High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat Biotechnol 18: 333-338.
30. Steinberg DA, Hurst MA, Fuji CA, Kung AHC, Ho JF, Cheng FC, Loury DJ, Fiddes JC (1997) Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 41: 1738-1742.
31. Streatfield S (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5: 2-15.
32. Terras FRG, Schoofs HME, De Bolle MFC, Leuvent FV, Rees SB, Vanderleyden J, Cammute BPA, Breoekaert WF (1992) Analysis of two novel classes of plant antifungal proteins from Radish (Raphanus sativus L.) seeds. J Biol Chem 267: 15301-15309.
33. Terras FRG, Eggermont K, Kovaleva V, Raikhel NV, Osborn RW, Kaster A, Rees SB, Torrekens S, van Leuven F, Vanderleyden J, Cammue BPA, Broekaert WF (1995) Small cysteine-rich antifungal proteins from radish: their role in host defense. Plant Cell 7: 573-588.
34. Tremblay R, Wang D, Jevnikar AM, Shengwu M (2010) Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol Adv 28: 214-221.
35. Von Haehling S, Morley JA, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1: 129-133.
36. WHO (2000). http://www. who. int/infectious-disease-report/2000/.
37. Willey JM, van der Donk WA (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61: 477-501.
38. Yeman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55: 27-55.
39. Zaiou M (2007) Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 85: 317-329.